To further explore the impact of TREM2+ macrophages on CD8+ T cells in the tumor microenvironment, we intrahepatically injected Hepa 1–6 cells in combination with WT or Trem2−/− BMDMs into WT mice and then harvested liver tumors for single-cell sequencing at the experimental endpoint. The gene discussed is CD8A; the disease is neoplasm.